Skip to main content

Table 2 Serum lipid concentration in diabetes patients and controls

From: Elevation of small, dense low density lipoprotein cholesterol—a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria

 

Diabetics

Controls

P-value

Variable

(n = 176)

(n = 154)

 
 

Mean ± SD

Mean ± SD

 

Total Cholesterol (mmol/L)

5.16 ± 1.31

4.35 ± 1.02

< 0.01

Triglycerides (mmol/L)

1.42 ± 0.63

1.00 ± 0.56

< 0.01

HDL-C (mmol/L)

1.21 ± 0.36

1.26 ± 0.40

0.19

LDL-C (mmol/L)

3.31 ± 1.20

2.60 ± 0.91

< 0.01

sdLDL-C (mmol/L)

1.45 ± 0.64

0.80 ± 0.54

< 0.01

lbLDL-C (mmol/L)

1.86 ± 1.09

1.84 ± 0.93

0.85

% LDL-C as sdLDL-C

45.0 ± 17.79

32.0 ± 15.93

< 0.01

TC/HDL-C

4.63 ± 2.40

3.69 ± 1.19

< 0.01

HDL-C/LDL/C

0.41 ± 0.19

0.56 ± 0.36

< 0.01

LDL-C/HDL-C

3.05 ± 2.22

2.29 ± 1.04

< 0.01

  1. Values are expressed as mean ± SD, Unpaired Student’s t-tests, P < 0.05 = significant